AMRX
Amneal Pharmaceuticals Inc - Class A
$12.48
-1.81% ($0.23)
Volume
1.35M
52W High
$15.42
52W Low
$6.69
Market Cap
$4.56B
What to Watch This Quarter
Based on historical dataConsensus EPS
$0.19
Whisper EPS
$0.22
14.5% above consensus
Last Quarter
$0.21
Current Streak
4 Beats
Avg Surprise (4Q)
+31.18%
Next Earnings Report
Reports in 24 days
Price Chart
EPS History: Consensus vs Actual
Last 12 quartersPrice Movement Around Earnings
Q4 2025
Feb 27, 2026
5-Day:
-3.69%
Q3 2025
Oct 30, 2025
1-Day:
+8.20%
5-Day:
+13.50%
Q2 2025
Aug 5, 2025
1-Day:
-0.98%
Q1 2025
May 2, 2025
5-Day:
-9.41%
Revenue & Financial Performance
Revenue Whisper
$792.0M
TWN Proprietary Estimate
Last Quarter Revenue
$814.3M
+11.5% YoY
Gross Margin
36.5%
Net Margin: 4.3%
| Quarter | Revenue | YoY Growth | Gross Margin | Op Margin | Net Income |
|---|---|---|---|---|---|
| Q4'25 | $814.3M | +11.5% | 36.5% | 14.1% | $35.1M |
| Q3'25 | $784.5M | +11.7% | 34.9% | 0.0% | $2.4M |
| Q2'25 | $724.5M | +3.2% | 39.5% | 15.4% | $22.4M |
| Q1'25 | $695.4M | +5.5% | 36.8% | 14.4% | $12.2M |
| Q4'24 | $730.5M | +18.4% | 36.0% | 10.4% | -$31.1M |
| Q3'24 | $702.5M | +13.3% | 38.4% | 12.6% | $-156,000 |
| Q2'24 | $701.8M | +17.2% | 35.6% | 13.6% | $6.0M |
| Q1'24 | $659.2M | +18.2% | 36.1% | -1.6% | -$91.6M |
Company Information
Symbol
AMRX
Company
Amneal Pharmaceuticals Inc - Class A
Market Cap
$4.56B
Next Earnings
May 1, 2026